Doctor profile · Federal record
Dr. Elizabeth Evers, M.D.
Dermatology Physician (CMS: Dermatology) · Nashville, TN
- NPI 1861412405
- Accepts Medicare
- MIPS 83.1 / 100 · 2023
- 37 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
7640 Highway 70 S, Suite 201
Nashville, TN 372211758
(615) 646-8098
fax (615) 646-8557
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- July 8, 2007
- Year of graduation
- 1989 — 37 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Tennessee #MD024557
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1861412405. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
4,344
Distinct HCPCS
10
Medicare allowed
$211,413
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,926 | 318 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 924 | 730 | $84 | |
17000 |
Destruction of precancer skin growth, 1 growth | 508 | 403 | $48 | |
17110 |
Destruction of skin growth, 1-14 growths | 336 | 267 | $97 | |
11104 |
Punch biopsy, first skin growth | 175 | 157 | $112 | |
11102 |
Biopsy of related skin growth, first growth | 96 | 88 | $79 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 78 | 71 | $52 | |
11105 |
Punch biopsy, each additional skin growth | 56 | 46 | $54 | |
11103 |
Biopsy of related skin growth, each additional growth | 53 | 40 | $46 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 49 | 37 | $155 |
In context: peer comparison
Among 22 peers in Nashville Dermatology Physician, average services per provider: 176. This provider delivers 25× the peer median.Open Payments
Industry payments received
All-time total
$1,213
Transactions
50
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, INC. | 16 | $416.48 | |
| Novartis Pharmaceuticals Corporation | 6 | $145.55 | |
| Abbvie INC. | 5 | $114.95 | |
| Lilly USA, LLC | 4 | $100.10 | |
| Exact Sciences Corporation | 4 | $90.51 | |
| Pfizer INC. | 3 | $60.64 | |
| Regeneron Healthcare Solutions, INC. | 1 | $39.51 | |
| AstraZeneca Pharmaceuticals Lp | 2 | $36.01 | |
| Azurity Pharmaceuticals, INC. | 2 | $35.78 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $35.61 | |
| Abbott Laboratories | 1 | $23.48 | |
| Antares Pharma, INC. | 1 | $21.11 | |
| Krystal Biotech INC | 1 | $20.93 | |
| Galderma Laboratories, L.P. | 1 | $20.21 | |
| Merck Sharp & Dohme LLC | 1 | $19.03 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
459
Patients
281
Total drug cost
$10,823
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 108 | 82 | $942 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 47 | 27 | $532 |
| Betamethasone Dipropionate | Generic | 44 | 26 | $1,640 |
| Ketoconazole | Generic | 43 | 28 | $1,168 |
| Terbinafine Hcl | Generic | 37 | 22 | $592 |
| Imiquimod | Generic | 32 | 13 | $946 |
| Metronidazole | Generic | 27 | 22 | $2,324 |
| Mupirocin | Generic | 27 | 14 | $180 |
| Erythromycin (Erythromycin Base in Ethanol) | Brand | 23 | 0 | $756 |
| Cephalexin | Generic | 22 | 17 | $229 |
Frequently asked questions
What is Dr. Elizabeth Evers's medical specialty?
Dr. Elizabeth Evers practices Dermatology Physician in Nashville, TN.
Where does Dr. Elizabeth Evers practice?
Dr. Elizabeth Evers practices at 7640 Highway 70 S, Nashville, TN 372211758. Office phone: 6156468098.
What is Dr. Elizabeth Evers's NPI?
Dr. Elizabeth Evers's National Provider Identifier (NPI) is 1861412405, issued by NPPES.
Does Dr. Elizabeth Evers accept Medicare assignment?
Yes. Dr. Elizabeth Evers accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Elizabeth Evers commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.